Endocrine-Related Cancer
Journal of Endocrinology (JOE)
Journal of Molecular Endocrinology (JME)
Endocrine-Related Cancer (ERC)
BioScientifica
Skip to main page content
HOME
ERC
About
Accepted MSS
New Articles
Free Reviews
Best Metabolism Booster
Best Testosterone Booster
Best Melatonin Supplement
RSS
Submit
HELP
Contact
Search for Keyword:
GO
Advanced Search
User Name
Password
Sign In
CrossRef Cited-by Linking Search Results
This Article:
Review
:
Stephen J Foulkes
,
Robin M Daly
,
and
Steve F Fraser
The clinical importance of quantifying body fat distribution during androgen deprivation therapy for prostate cancer
Endocr Relat Cancer
24
(
3
)
R35
-
R48
, doi:
10.1530/ERC-16-0505
first published on
6 January 2017
Abstract
Full Text
Full Text (PDF)
Figures Only
has not yet been cited by articles in journals that are participating in CrossRef Cited-by Linking.
New Articles: issue in progress
November 2017, 24 (11)
Alert me to new issues of
Endocrine-Related Cancer
About this journal
Overview
Editorial board
Endorsing societies
For authors
Instructions for authors
Ethical guidelines
Bioscientifica Open Access policy
For readers
Editor's choice
Most cited
/
most read
Recommend this journal to your library
Permissions information
Journal-based learning
For libraries
Information for libraries
Sales and corporate services
Sales and advertising
Further links
Society for Endocrinology
About Society for Endocrinology journals
About Bioscientifica journals
Terms and conditions
Tweets by @EndoCancer
Most
Viewed
Association of Hashimoto's thyroiditis with thyroid cancer
p53 and breast cancer, an update
Insulin resistance and cancer: the role of insulin and IGFs
Progesterone metabolites in breast cancer
The emerging roles of DNA methylation in the clinical management of prostate cancer
» View all Most Viewed articles
Cited
Fibroblast growth factors, their receptors and signaling
The epidermal growth factor receptor family as a central element for cellular signal transduction and diversification
BRAF mutation in thyroid cancer
mTOR, a novel target in breast cancer: the effect of CCI-779, an mTOR inhibitor, in preclinical models of breast cancer
Discovery of a novel Raf kinase inhibitor
» View all Most Cited articles